Valiant Laboratories Ltd. Hits Upper Circuit on BSE, 28 October 2026

Bids outweighed offers by the time the Valiant Laboratories upper circuit formed on BSE: Valiant Laboratories Ltd. reached Rs 126.65 on 28 October 2026, 1.97% above the previous close of Rs 124.2, from an opening print of Rs 121.75. The market cap is Rs 674.56 crore.

A participant looking to deal in the stock today meets that imbalance first, since the price has stopped at the band and orders on the other side are scarce, which sets the terms for any trade.

Key Takeaways

• Valiant Laboratories Ltd. (VALIANTLAB) hit the upper circuit on BSE at Rs 126.65 on 28 October 2026.
• The session move was +1.97% against a previous close of Rs 124.2.
• Market capitalisation stood at Rs 674.56 crore with a PE ratio of 42.14.
• No official company announcement or verified catalyst was confirmed at the time of writing.
• A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

All figures above are as of 28 October 2026, sourced from Univest market data for the BSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

Valiant Laboratories Ltd. opened at Rs 121.75, under the previous close of Rs 124.2, and that opening level was also the low of the session. The price then climbed through the previous close to Rs 126.65, which is the day high and the band price.

The change is Rs 2.45, or 1.97%. A session that starts under the prior level and ends its climb at the limit covers a wider span than the percentage change suggests.

All the numbers are from BSE, so the open, the range and the previous close sit together on one exchange.

Why Valiant Laboratories Ltd. Hit Upper Circuit

Demand carried Valiant Laboratories Ltd. from its lower opening to the price band, and the upper circuit held the price at Rs 126.65. Neither a company disclosure nor a verified outside catalyst was on record, so price action and sentiment are the only reading offered.

Healthcare news, results, corporate actions and rumours are not named as drivers. A confirmed development would be added in a separate update, and the move is treated as a price event alone until one is verified, with no cause assigned in the meantime.

What the Valiant Laboratories Upper Circuit Means

Seen through the order book, the upper circuit is the point above which the exchange allows no trade for the session. For Valiant Laboratories Ltd. that point was Rs 126.65 on 28 October 2026.

Bands are meant to cool abrupt moves and keep trading orderly. They are a market rule and not a return forecast, and a price held at the limit says nothing about what the book will look like in later sessions, only about this one.

Valiant Laboratories Ltd. Fundamentals and Valuation

Reported data supplies detail the price cannot. Valiant Laboratories Ltd. sits in Healthcare, under Pharmaceuticals & Drugs, with EPS of 2.95, book value of Rs 61.13, a PE ratio of 42.14 and a PB ratio of 2.03, on a market cap of Rs 674.56 crore. None of these is a buy, sell or hold view.

EPS and return on equity disagree in the source figures, so they cannot both be right, and no conclusion on profitability is drawn until they are reconciled.

The price stands at roughly twice the Rs 61.13 book value per share, which is what the PB ratio of 2.03 says, while the PE ratio of 42.14 sets the same price against EPS of 2.95. Premiums of this kind can come from growth expectations, asset quality or limited trading in a smaller counter.

Trading at the band says something about the order book on the day, yet it says little about valuation, which needs its own review that sets the price event aside.

Peer and Sector Context

Valiant Laboratories Ltd. belongs to the Pharmaceuticals & Drugs industry within the Healthcare sector. The peer table below uses available companies from the same sector or industry to give broader valuation context.

A dash in the PE column means no PE ratio was carried for that company in the source data, which happens when reported earnings are negative or have not been refreshed. Those companies are left out of the average below rather than counted as zero.

Several of these peers are far larger by market capitalisation than Valiant Laboratories Ltd. Size differences change liquidity and cost of capital, so the table is sector context rather than a like-for-like ranking.

Valiant Laboratories Ltd.’s PE ratio was 42.14, compared with an available peer PE average of 64.76, calculated from the 4 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.

Technical Snapshot

The technical snapshot adds context: RSI was 92.93, the 50-day moving average was 125.02 and the 200-day moving average was 88.8.

What Readers Should Know

The practical limit after a session at the band is execution: with the book tilted to buyers at Rs 126.65, a new buy order may wait unfilled because few holders are selling, and the displayed price is not a promise of a fill.

Two points are firm. Valiant Laboratories Ltd. was quoted at Rs 126.65 on BSE on 28 October 2026, which is the upper circuit level, a 1.97% rise, and nothing official was confirmed as a catalyst at the time of writing.

This note is a market update and stops there. The company itself, its pricing, the ease of trading its shares and its filings all lie outside what a single quote at the band can show, and each needs its own check.

Frequently Asked Questions

Why did Valiant Laboratories Ltd. hit upper circuit on 28 October 2026?

The stock reached its upper price band after buying interest during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

What was VALIANTLAB share price on 28 October 2026?

The last traded price used in this article was Rs 126.65 on BSE. That price matched the upper circuit price captured for the event.

What was the upper circuit price for VALIANTLAB?

The upper circuit price was Rs 126.65. The stated exchange upper circuit limit was Rs 126.65. The event numbers in this article are aligned to BSE.

What is Valiant Laboratories Ltd.’s market cap and PE ratio?

Valiant Laboratories Ltd.’s market cap was Rs 674.56 crore. PE ratio was 42.14.

Which exchange and data source were used?

The selected exchange was BSE. The article uses Univest market data available at the time of generation, captured on 28 October 2026.

Does hitting an upper circuit mean Valiant Laboratories Ltd. is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell Valiant Laboratories Ltd. shares when the stock is at the upper circuit?

It is usually difficult. At the upper circuit, buy orders queue up while sellers step back, so there may be no counterparty at the quoted price. Orders can stay unfilled until the band opens up or sellers return.

What happens the next trading session after an upper circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the upper circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Valiant Laboratories Ltd. the stated limit was Rs 126.65. For this session, Valiant Laboratories Ltd. moved 1.97%.